Germline testing for predisposition to ovarian/breast cancer should be routinely recommended in all patients with invasive epithelial ovarian cancer

被引：0
|
作者：
Wheeler L.J. [1 ]
Guntupalli S. [1 ]
机构：
[1] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado Denver, School of Medicine, Anschutz Medical Campus, 12631 East 17th Avenue B198-6, Aurora, 80045, CO
来源：
Indian Journal of Gynecologic Oncology | 2017年 / 15卷 / Suppl 1期
关键词：
Genetic testing; Ovarian cancer; Universal screening;
D O I：
10.1007/s40944-017-0164-7
中图分类号：
学科分类号：
摘要：
Given the marked prevalence of germline mutations among women with ovarian cancer, we recommend universal BRCA genetic screening, regardless of patient age or family history. © Association of Gynecologic Oncologists of India 2017.
引用
收藏
页码：S27 / S30
页数：3
相关论文
共 50 条
  • [21] BRCA1 mutation testing for Japanese patients with ovarian cancer in breast cancer screening
    Yamashita, Y
    Sagawa, T
    Fujimoto, T
    Sugawara, T
    Yamada, H
    Hoshi, N
    Sakuragi, N
    Ishioka, C
    Fujimoto, S
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 58 (01) : 11 - 17
  • [22] Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics
    Kentwell, Maira
    Dow, Eryn
    Antill, Yoland
    Wrede, C. David
    McNally, Orla
    Higgs, Emily
    Hamilton, Anne
    Ananda, Sumitra
    Lindeman, Geoffrey J.
    Scott, Clare L.
    GYNECOLOGIC ONCOLOGY, 2017, 145 (01) : 130 - 136
  • [23] BRCA germline mutation test for all woman with ovarian cancer?
    A. V. Paradiso
    M. Digennaro
    M. Patruno
    S. De Summa
    S. Tommasi
    I. Berindan-Neagoe
    BMC Cancer, 19
  • [24] Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience
    Rummel, Seth K.
    Lovejoy, Leann A.
    Turner, Clesson E.
    Shriver, Craig D.
    Ellsworth, Rachel E.
    CANCERS, 2020, 12 (01)
  • [25] Treatment for infertility and risk of invasive epithelial ovarian cancer
    Parazzini, F
    Negri, E
    La Vecchia, C
    Moroni, S
    Franceschi, S
    Crosignani, PG
    HUMAN REPRODUCTION, 1997, 12 (10) : 2159 - 2161
  • [26] RAD51C germline mutations in breast and ovarian cancer patients
    Mohammad R Akbari
    Patricia Tonin
    William D Foulkes
    Parviz Ghadirian
    Marc Tischkowitz
    Steven A Narod
    Breast Cancer Research, 12
  • [27] Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients
    ER Thompson
    SE Boyle
    J Johnson
    GL Ryland
    S Sawyer
    DY Choong
    G Chenevix-Trench
    AH Trainer
    GJ Lindeman
    G Mitchell
    PA James
    IG Campbell
    Hereditary Cancer in Clinical Practice, 10 (Suppl 2)
  • [28] Analysis of RAD51C Germline Mutations in High-Risk Breast and Ovarian Cancer Families and Ovarian Cancer Patients
    Thompson, Ella R.
    Boyle, Samantha E.
    Johnson, Julie
    Ryland, Georgina L.
    Sawyer, Sarah
    Choong, David Y. H.
    Chenevix-Trench, Georgia
    Trainer, Alison H.
    Lindeman, Geoffrey J.
    Mitchell, Gillian
    James, Paul A.
    Campbell, Ian G.
    HUMAN MUTATION, 2012, 33 (01) : 95 - 99
  • [29] Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing
    Tuncer, Seref Bugra
    Celik, Betul
    Erciyas, Seda Kilic
    Erdogan, Ozge Sukruoglu
    Gultaslar, Busra Kurt
    Odemis, Demet Akdeniz
    Avsar, Mukaddes
    Sen, Fatma
    Saip, Pinar Mualla
    Yazici, Hulya
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 254
  • [30] Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families
    Kirsi M. Määttä
    Riikka Nurminen
    Minna Kankuri-Tammilehto
    Anne Kallioniemi
    Satu-Leena Laasanen
    Johanna Schleutker
    BMC Cancer, 17
12345